recordati – Lab DB

Pharmaceutical R&D

Ionis Pharmaceuticals and Recordati Forge Global Partnership for Zilganersen in Alexander Disease

Teuku Ryan Jun 28, 2026 0

Ionis Pharmaceuticals has forged a significant global licensing agreement with Recordati, a prominent international pharmaceutical company, granting Recordati exclusive rights…

CVC Capital Partners and Groupe Bruxelles Lambert Launch $12.4 Billion Takeover Bid for Recordati, Signaling Potential Shift to Private Ownership

Teuku Ryan May 23, 2026 0

One of Italy’s few remaining publicly traded large pharmaceutical companies, Recordati, is on the cusp of transitioning to private ownership…

Recordati Weighs CVC’s €10.9 Billion Acquisition Offer, Potentially Delisting from Italian Stock Exchange

Teuku Ryan Mar 27, 2026 0

Italian pharmaceutical giant Recordati is currently in deliberations regarding a significant acquisition offer from global private equity firm CVC Capital…

Ionis Pharmaceuticals and Recordati Forge Global Partnership for Zilganersen in Alexander Disease

CVC Capital Partners and Groupe Bruxelles Lambert Launch $12.4 Billion Takeover Bid for Recordati, Signaling Potential Shift to Private Ownership

Recordati Weighs CVC’s €10.9 Billion Acquisition Offer, Potentially Delisting from Italian Stock Exchange

YOU MAY HAVE MISSED

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286

Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition

Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation